                         SEQUENCE LISTING

<110>  UNIVERSITE GRENOBLE ALPES
       INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
       CENTRE HOSPITALIER UNIVERSITAIRE DE GRENOBLE
 
<120>  Oligonuclotides anti-sens pour leur utilisation dans un 
       traitement anticancreux

<130>  34413 WO

<150>  FR2102992
<151>  2021-03-25

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  ANTISENSE OLIGONUCLEOTIDE FOR TARGETING HUMAN HTT RNA

<400>  1
ctcagtaaca ttgacaccac                                                   20


<210>  2
<211>  20
<212>  DNA
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  ANTISENSE OLIGONUCLEOTIDE TARGETING HUMAN HTT RNA

<400>  2
tctctattgc acattccaag                                                   20


<210>  3
<211>  20
<212>  DNA
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  ANTISENSE OLIGONUCLEOTIDE TARGETING HUMAN HTT RNA

<400>  3
ctcgactaaa gcaggatttc                                                   20


<210>  4
<211>  20
<212>  DNA
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  ANTISENSE OLIGONUCLEOTIDE TARGETING HUMAN HTT RNA

<400>  4
cctgcatcag ctttatttgt                                                   20


<210>  5
<211>  20
<212>  DNA
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  ANTISENSE OLIGONUCLEOTIDE USED AS CONTROL IN EXPERIMENTS


<220>
<221>  misc_feature
<222>  (1)..(5)
<223>  2'-O-methoxyethyl RNA sequence

<220>
<221>  misc_feature
<222>  (1)..(2)
<223>  phosphorothioate bond

<220>
<221>  misc_feature
<222>  (5)..(16)
<223>  phosphorothioate bonds

<220>
<221>  misc_feature
<222>  (6)..(15)
<223>  DNA SEQUENCE

<220>
<221>  misc_feature
<222>  (16)..(20)
<223>  2'-O-methoxyethyl RNA sequence

<220>
<221>  misc_feature
<222>  (19)..(20)
<223>  phosphorothioate bond

<400>  5
acatgaccgc actcactata                                                   20


